These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 25052410)

  • 1. Studying the antiemetic effect of vitamin B6 for morning sickness: pyridoxine and pyridoxal are prodrugs.
    Matok I; Clark S; Caritis S; Miodovnik M; Umans JG; Hankins G; Mattison DR; Koren G
    J Clin Pharmacol; 2014 Dec; 54(12):1429-33. PubMed ID: 25052410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic bioavailability and pharmacokinetics of the doxylamine-pyridoxine delayed-release combination (Diclectin).
    Gill SK; Garcia-Bournissen F; Koren G
    Ther Drug Monit; 2011 Feb; 33(1):115-9. PubMed ID: 21079545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing pyridoxine and doxylamine succinate-pyridoxine HCl for nausea and vomiting of pregnancy: A matched, controlled cohort study.
    Pope E; Maltepe C; Koren G
    J Clin Pharmacol; 2015 Jul; 55(7):809-14. PubMed ID: 25663469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy.
    Koren G; Clark S; Hankins GD; Caritis SN; Umans JG; Miodovnik M; Mattison DR; Matok I
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):371. PubMed ID: 27881103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the pharmacokinetics of doxylamine/pyridoxine delayed-release combination in nonpregnant women of reproductive age and women in the first trimester of pregnancy.
    Matok I; Clark S; Caritis S; Miodovnik M; Umans J; Hankins G; Koren G
    J Clin Pharmacol; 2013 Mar; 53(3):334-8. PubMed ID: 23444286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should doxylamine-pyridoxine be used for nausea and vomiting of pregnancy?
    Persaud N; Chin J; Walker M
    J Obstet Gynaecol Can; 2014 Apr; 36(4):343-348. PubMed ID: 24798673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA approval of doxylamine-pyridoxine therapy for use in pregnancy.
    Slaughter SR; Hearns-Stokes R; van der Vlugt T; Joffe HV
    N Engl J Med; 2014 Mar; 370(12):1081-3. PubMed ID: 24645939
    [No Abstract]   [Full Text] [Related]  

  • 8. The return to the USA of doxylamine-pyridoxine delayed release combination (Diclegis®) for morning sickness--a new morning for American women.
    Koren G
    J Popul Ther Clin Pharmacol; 2013; 20(2):e161-2. PubMed ID: 23863487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in the pharmacokinetics and bioequivalence of the delayed-release combination of doxylamine succinate-pyridoxine hydrochloride; implications for pharmacotherapy in pregnancy.
    Koren G; Vranderick M; Gill SK; Macleod S
    J Clin Pharmacol; 2013 Dec; 53(12):1268-76. PubMed ID: 24123059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of doxylamine-pyridoxine for morning sickness.
    Koren G; Hankins GD; Clark S; Caritis SN; Miodovnik M; Umans JG; Mattison DR
    Am J Obstet Gynecol; 2016 May; 214(5):664-6. PubMed ID: 26844757
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of women with nausea and vomiting of pregnancy who chose to continue compassionate use of placebo after a randomised trial.
    Matok I; Umans J; Feghali MN; Clark S; Caritis S; Miodovnik M; Hankins G; Mattison DR; Nordeng H; Koren G
    J Obstet Gynaecol; 2013 Aug; 33(6):557-60. PubMed ID: 23919849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flawed invisible trial underpins US morning sickness drug, researchers say.
    Dyer O
    BMJ; 2017 Jan; 356():j132. PubMed ID: 28069575
    [No Abstract]   [Full Text] [Related]  

  • 13. Critical appraisal of drug therapy for nausea and vomiting of pregnancy: II. Efficacy and safety of diclectin (doxylamine-B6).
    Bishai R; Mazzotta P; Atanackovic G; Levichek Z; Pole M; Magee LA; Koren G
    Can J Clin Pharmacol; 2000; 7(3):138-43. PubMed ID: 11044759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new pharmacologic treatment for nausea and vomiting of pregnancy.
    Fantasia HC
    Nurs Womens Health; 2014; 18(1):73-77. PubMed ID: 24548499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating morning sickness in the United States--changes in prescribing are needed.
    Koren G
    Am J Obstet Gynecol; 2014 Dec; 211(6):602-6. PubMed ID: 25151184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic comparison of a delayed-release combination of doxylamine succinate and pyridoxine hydrocholoride (Diclectin) and oral solutions of these drugs in healthy women of childbearing age.
    Nulman I; Koren G
    Can J Clin Pharmacol; 2009; 16(3):e400-6. PubMed ID: 19923636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial.
    Koren G; Clark S; Hankins GD; Caritis SN; Miodovnik M; Umans JG; Mattison DR
    Am J Obstet Gynecol; 2010 Dec; 203(6):571.e1-7. PubMed ID: 20843504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing recurrence of severe morning sickness.
    Koren G; Maltepe C
    Can Fam Physician; 2006 Dec; 52(12):1545-6. PubMed ID: 17279232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-Way Randomized Controlled Trial of Doxylamine, Pyridoxine and Dicyclomine for Nausea and Vomiting during Pregnancy: Restoration of Unpublished Information.
    Zhang R; Persaud N
    PLoS One; 2017; 12(1):e0167609. PubMed ID: 28052111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancy.
    Madjunkova S; Maltepe C; Koren G
    Paediatr Drugs; 2014 Jun; 16(3):199-211. PubMed ID: 24574047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.